Physician profile
Eric W Czander
NPI 1912997545
$8,811.12
in general payments reported to CMS, 2019-2025
46 companies · $928 in 2025
The $928 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,780 · 2020: $790 · 2021: $1,019 · 2022: $1,348 · 2023: $1,549 · 2024: $1,397 · 2025: $928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,874.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,105.93 | 2021-2025 | Ubrelvy, Qulipta |
| Supernus Pharmaceuticals, INC. | $889.23 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $672.10 | 2019-2025 | |
| Eisai INC. | $653.71 | 2019-2025 | |
| Biogen, INC. | $605.62 | 2019-2024 | Vumerity, Tysabri |
| Lilly USA, LLC | $481.70 | 2019-2025 | Amyvid, Kisunla, Emgality |
| Pfizer INC. | $424.05 | 2023-2025 | |
| Genentech USA, INC. | $408.60 | 2022-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Ucb, INC. | $400.39 | 2019-2025 | Nayzilam, Briviact |
| Sunovion Pharmaceuticals INC. | $358.36 | 2019-2022 | |
| Genzyme Corporation | $323.79 | 2019-2022 | |
| Mdd US Operations, LLC | $262.27 | 2019-2024 | Gocovri |
| Emd Serono, INC. | $243.08 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $242.09 | 2023-2024 | Aptiom |
| Neurelis, INC. | $188.34 | 2020-2025 | Valtoco |
Show all 45 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Czander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.